Who is sponsoring NCT06361953?

NCT06361953 is sponsored by Shahid Beheshti University of Medical Sciences.

What condition does NCT06361953 study?

NCT06361953 studies Generalized Anxiety Disorder.

What drugs are being tested in NCT06361953?

Interventions: EEG Neurofeedback.

What is the status of NCT06361953?

NCT06361953 is currently COMPLETED.

Last reviewed 2024-04-12 · How we verify

Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder

NCT06361953 NA COMPLETED

Generalized anxiety disorder (GAD) is one of the most prevalent mental disorders in adults, marked by excessive and uncontrollable worry about various events or activities. It is accompanied by symptoms such as restlessness, irritability, fatigue, difficulty concentrating, problems with sleep, and somatic symptoms. In addition, a critical and up-to-date comparison of different treatments for GAD is crucial due to their high costs and unsatisfactory outcomes. EEG neurofeedback training has not reached the same level of evidence as more extensively validated non-pharmacological treatments, such as cognitive behavioral therapy.This study aimed to compare the efficacy of two protocols: one targeting alpha-theta amplitude increase and the other concentrating on SMR.

Details

Lead sponsor	Shahid Beheshti University of Medical Sciences
Phase	NA
Status	COMPLETED
Enrolment	40
Start date	Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Jul 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Generalized Anxiety Disorder

Interventions

EEG Neurofeedback

Countries

Iran